Genolimzumab

Genolimzumab Uses, Dosage, Side Effects, Food Interaction and all others data.

Genolimzumab is under investigation in clinical trial NCT03502629 (Clinical Trial in Chinese Patients of Relapsed and Refractory Peripheral T Cell Lymphoma (GB226)).

Trade Name Genolimzumab
Generic Geptanolimab
Geptanolimab Other Names Genolimzumab, Geptanolimab
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Genolimzumab
Genolimzumab

Innovators Monograph

You find simplified version here Genolimzumab


*** Taking medicines without doctor's advice can cause long-term problems.
Share